Ignite Creation Date:
2024-05-05 @ 10:00 AM
Last Modification Date:
2024-10-26 @ 9:04 AM
Study NCT ID:
NCT00004829
Status:
COMPLETED
Last Update Posted:
2015-03-25
First Post:
2000-02-24
Brief Title:
Phase III Randomized Study of the Inhalation of Tobramycin in Patients With Cystic Fibrosis
Sponsor:
FDA Office of Orphan Products Development
Organization:
FDA Office of Orphan Products Development
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Bacterial Infection |
| Cystic Fibrosis |